Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PROK ProKidney Corp. Class A Ordinary Shares
$1.82 1.11% +0.02
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PROK stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 718.5M
Enterprise value 1.3B
Trailing PE -3.5
Forward PE -3.0692105
PEG Ratio -0.2275
Enterprise to EBITDA -7.656
Enterprise to revenue 1594.618
Price to book MRQ 1.5237123748194
Price to sales TTM 878.3968

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 818.0K
EBITDA -170370000
Diluted EPS TTM -0.55
Total Cash (MRQ) 181.6M
Current ratio (MRQ) 8.356
Operating Cash Flow (TTM) -141167008

PROK trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.